Clearmind Medicine Common Stock Buy Hold or Sell Recommendation
| CMND Stock | USD 1.38 0.01 0.73% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Clearmind Medicine Common is 'Cautious Hold'. Macroaxis provides Clearmind Medicine buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CMND positions.
Check out Clearmind Medicine Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Clearmind and provide practical buy, sell, or hold advice based on investors' constraints. Clearmind Medicine Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Clearmind |
Execute Clearmind Medicine Buy or Sell Advice
The Clearmind recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Clearmind Medicine Common. Macroaxis does not own or have any residual interests in Clearmind Medicine Common or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Clearmind Medicine's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Weak | Details | |
Volatility | Abnormally volatile | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Clearmind Medicine Trading Alerts and Improvement Suggestions
| Clearmind Medicine had very high historical volatility over the last 90 days | |
| Clearmind Medicine may become a speculative penny stock | |
| Clearmind Medicine Common currently holds 53.14 K in liabilities. Clearmind Medicine Common has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Clearmind Medicine's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (5.25 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Clearmind Medicine Common currently holds about 1.65 K in cash with (4.86 M) of positive cash flow from operations. | |
| Clearmind Medicine has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Clearmind Medicine Announces Shareholders Meeting Results - The Manila Times |
Clearmind Medicine Returns Distribution Density
The distribution of Clearmind Medicine's historical returns is an attempt to chart the uncertainty of Clearmind Medicine's future price movements. The chart of the probability distribution of Clearmind Medicine daily returns describes the distribution of returns around its average expected value. We use Clearmind Medicine Common price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Clearmind Medicine returns is essential to provide solid investment advice for Clearmind Medicine.
| Mean Return | -0.0094 | Value At Risk | -8.84 | Potential Upside | 6.25 | Standard Deviation | 6.61 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Clearmind Medicine historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Clearmind Stock Institutional Investors
| Shares | Gotham Asset Management, Llc | 2024-09-30 | 339 K | Advisorshares Investments, Llc | 2024-09-30 | 170.6 K | Ubs Group Ag | 2024-09-30 | 141.3 K | Cornerstone Wealth Group, Llc | 2024-12-31 | 20 K | Citadel Advisors Llc | 2024-09-30 | 17.7 K | Hrt Financial Llc | 2024-09-30 | 12.8 K | Royal Bank Of Canada | 2024-09-30 | 569 | Susquehanna International Group, Llp | 2024-06-30 | 0.0 | Geode Capital Management, Llc | 2024-09-30 | 0.0 |
Clearmind Medicine Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 4.3M | (4.4M) | 3.8M | 1.1M | 1.3M | 1.4M | |
| Net Income | (3.9M) | (9.4M) | (6.2M) | (5.3M) | (4.7M) | (4.5M) | |
| End Period Cash Flow | 4.6M | 175.8K | 3.9M | 6.6M | 7.6M | 7.9M | |
| Free Cash Flow | (3.1M) | (5.1M) | (6.3M) | (4.9M) | (4.4M) | (4.6M) | |
| Depreciation | 2.6K | 113.4K | 41.6K | 51.1K | 46.0K | 64.9K | |
| Other Non Cash Items | 189.7K | 836.9K | 210.7K | (512.7K) | (461.4K) | (438.4K) | |
| Change To Inventory | 28.0 | 157.7K | (27.2K) | 151.5K | 174.2K | 182.9K | |
| Investments | (251.2K) | (7.6K) | (26.2K) | (238.1K) | (214.3K) | (203.6K) |
Clearmind Medicine Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Clearmind Medicine or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Clearmind Medicine's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Clearmind stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.07 | |
β | Beta against Dow Jones | 0.51 | |
σ | Overall volatility | 6.84 | |
Ir | Information ratio | -0.02 |
Clearmind Medicine Volatility Alert
Clearmind Medicine Common is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Clearmind Medicine's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Clearmind Medicine's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Clearmind Medicine Fundamentals Vs Peers
Comparing Clearmind Medicine's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Clearmind Medicine's direct or indirect competition across all of the common fundamentals between Clearmind Medicine and the related equities. This way, we can detect undervalued stocks with similar characteristics as Clearmind Medicine or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Clearmind Medicine's fundamental indicators could also be used in its relative valuation, which is a method of valuing Clearmind Medicine by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Clearmind Medicine to competition |
| Fundamentals | Clearmind Medicine | Peer Average |
| Return On Equity | -2.68 | -0.31 |
| Return On Asset | -0.58 | -0.14 |
| Current Valuation | (379.8 K) | 16.62 B |
| Shares Outstanding | 4.69 M | 571.82 M |
| Shares Owned By Insiders | 1.48 % | 10.09 % |
| Shares Owned By Institutions | 16.02 % | 39.21 % |
| Number Of Shares Shorted | 410.38 K | 4.71 M |
| Price To Earning | (750.00) X | 28.72 X |
| Price To Book | 2.07 X | 9.51 X |
| EBITDA | (5.85 M) | 3.9 B |
| Net Income | (5.25 M) | 570.98 M |
| Cash And Equivalents | 1.65 K | 2.7 B |
| Total Debt | 53.14 K | 5.32 B |
| Current Ratio | 0.03 X | 2.16 X |
| Book Value Per Share | 0.87 X | 1.93 K |
| Cash Flow From Operations | (4.86 M) | 971.22 M |
| Short Ratio | 0.23 X | 4.00 X |
| Earnings Per Share | (1.69) X | 3.12 X |
| Beta | -1.51 | -0.15 |
| Market Capitalization | 6.34 M | 19.03 B |
| Total Asset | 7.26 M | 29.47 B |
| Retained Earnings | (24.02 M) | 9.33 B |
| Working Capital | 2.96 M | 1.48 B |
| Net Asset | 7.26 M |
Note: Disposition of tradable shares by Lamadrid David of Clearmind Medicine subject to Rule 16b-3 [view details]
Clearmind Medicine Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Clearmind . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Clearmind Medicine Buy or Sell Advice
When is the right time to buy or sell Clearmind Medicine Common? Buying financial instruments such as Clearmind Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Clearmind Medicine in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Wireless Thematic Idea Now
Wireless
Companies providing wireless technology and communication services. The Wireless theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Wireless Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Clearmind Medicine Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clearmind Medicine. If investors know Clearmind will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clearmind Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Clearmind Medicine Common is measured differently than its book value, which is the value of Clearmind that is recorded on the company's balance sheet. Investors also form their own opinion of Clearmind Medicine's value that differs from its market value or its book value, called intrinsic value, which is Clearmind Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clearmind Medicine's market value can be influenced by many factors that don't directly affect Clearmind Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clearmind Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clearmind Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clearmind Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.